Telix Pharmaceuticals Limited (TLPPF) Financials

TLPPF Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 2.0 billion 870.9 million
Dec. 31, 2025 1.8 billion 767.7 million
June 30, 2025 1.8 billion 774.9 million
Dec. 31, 2024 1.5 billion 589.2 million

TLPPF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 5.8 million ?
Dec. 31, 2025 -94.5 million ?
June 30, 2025 16.8 million 17.6 million
Dec. 31, 2024 -10.9 million ?

TLPPF Net Income

No data available :(

TLPPF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 363.1 million 503.0 million 59.3 million
Dec. 31, 2025 212.7 million 392.2 million 62.2 million
June 30, 2025 317.8 million 374.8 million 34.4 million
Dec. 31, 2024 710.3 million 342.9 million 10.6 million

TLPPF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 356.9 million
Dec. 31, 2025 338.8 million
June 30, 2025 337.2 million
Dec. 31, 2024 345.2 million

TLPPF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 18.6 million 121.7 million 133.8 million -
Dec. 31, 2025 26.8 million 91.4 million 124.3 million -
June 30, 2025 6.7 million 81.5 million 96.6 million 74.4 million
Dec. 31, 2024 12.6 million 46.8 million 69.5 million 48.2 million

TLPPF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 469.0 million 328.5 million
Dec. 31, 2025 421.3 million 297.9 million
June 30, 2025 390.0 million 304.8 million
Dec. 31, 2024 369.2 million 208.4 million

TLPPF

Price: $10.24

52 week price:
5.91
13.00

Earnings Per Share: 0.10 USD

P/E Ratio: 113.70

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.6 billion

Links: